1. The Role of Induction (Neoadjuvant) Chemotherapy in Stage IIIA NSCLC
Rafael Rosell, MD, Albert Font, MD, Alex Pifarré, MD, Mercedes Canela, MD, PhD, Joan Maurel, MD, Antonio Arellano, MD, PhD, José Izquierdo, MD, PhD 
CHEST 
Volume 109, Issue 5, Pages 102S-106S (May 1996)
DOI: /chest.109.5_Supplement.102S
Copyright © 1996 The American College of Chest Physicians Terms and Conditions

2. Figure 1
New approaches in the management of NSCLC. The numbers in the box after surgery are percentage survival figures at 1 to 6 years, taken from the Toronto study.13
CHEST  , 102S-106SDOI: ( /chest.109.5_Supplement.102S)
Copyright © 1996 The American College of Chest Physicians Terms and Conditions